Skip to main content
Priyanka (Surana) Sharma, MD, Oncology, Westwood, KS

Priyanka (Surana) Sharma MD

Breast Cancer, Hematologic Oncology


Associate Professor of Medicine, Department of Internal Medicine

Join to View Full Profile
  • 2330 Shawnee Mission PkwySte 210Westwood, KS 66205

  • Phone+1 913-588-6029

  • Fax+1 913-588-9822

Dr. Sharma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Kansas School of Medicine
    University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005
  • University of Kansas School of Medicine
    University of Kansas School of MedicineChief Residency, Internal Medicine, 2001 - 2002
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Internal Medicine, 1999 - 2001
  • Baroda Medical College
    Baroda Medical CollegeClass of 1997

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2021 - 2026
  • KS State Medical License
    KS State Medical License 2001 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel  
    Amanda Amin, Jamie Wagner, Qamar J Khan, Roy A Jensen, Joshua M Mammen, Priyanka Sharma, Jennifer R Klemp, Clinical Cancer Research

Lectures

  • Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast canc... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • RSClin Tool N+ Enhances Breast Cancer Risk Estimates
    RSClin Tool N+ Enhances Breast Cancer Risk EstimatesJanuary 23rd, 2025
  • Trial Data Helped Guide Treatment of Stage II-III Triple-Negative Breast Cancer
    Trial Data Helped Guide Treatment of Stage II-III Triple-Negative Breast CancerDecember 11th, 2024
  • Summing It Up: Neoadjuvant Therapy in Triple-Negative Disease
    Summing It Up: Neoadjuvant Therapy in Triple-Negative DiseaseApril 6th, 2023
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: